Patients cannot easily turn their personal health data into accurate, individual treatment plans

IIntelligent agents can now analyze personalized health data from diagnostics, genome scans, EHR records, and wearables to deliver accurate individual treatment recommendations, while genome sequencing costs have fallen below Moore's Law rates. Today most patients still lack a way to assess disease risk accurately or access personalized therapies for serious illness. The need is startups that support this ecosystem and democratize access to personalized treatment.